Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (238)	11/24/1997 4:57:00 AM
From: James Baker	Read Replies (2) \| Respond to of 569

to all, regarding SYNVISC vs NSAIDS I attended a lecture last wk by a local rheumatologist. The main topic was appropriate use of NSAIDS but he made that comment that for someone with isolated OA of the knee HA products are a very good alternative regarding benfits and side effects. Jim

To: chirodoc who wrote (238)	11/24/1997 7:57:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 569

chirodoc <<......but i can't imagine they would sacrifice a lead in a new blockbuster when there are so many other indications for nsaid's--knee O/A is only a small part of their universe.>> Uhhh ... I think you nailed me but good! Your right - of course. Its illogical. And I was being illogical. What's got me crazed a little though is I've been diDE-boppin the web and along the way I found out that there are 7.0 mil. visits a year to doctors for O/A. Lets fight about the daily number, I'll include Sundays in the denominator and round down - that's 19,000 visits a day. My Good God! That's a lot of business. In addition, I researched ALL the classes and labs offered at that 1997 November Conference of Rheumatology and found some great studies on CroMagnin man and assorted dogs and cats, and a few new promising NSAID's - but no Synvisc, or Orthovisc or ANYKindOfVISC. I know, I know - probably have to submit papers 6 months before hand so we missed the window. Anyway - we'll just have to see. Have a good week. Regards, John